menu
    • menu

    Company profile for Faron Pharmaceuticals

    NEW Drugs in Dev: 3
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, today announces that, due to the prevailing Covid-19 situation, the Company's Board of Directors has decided to cancel the Company's annual general meeting ("AGM") scheduled to be held on 15 April 2020.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Faron PharmaceuticalsFinland Flag
    Country
    Country
    Finland
    Address
    Address
    Joukahaisenkatu 6 FI-20520 TURKU
    Telephone
    Telephone
    +358 2 469 5151
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.faron.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Faron Pharma: Extraordinary General Meeting Notice
    Faron Pharma: Extraordinary General Meeting Notice

    09 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-09/faron-pharmaceuticals-ltd-notice-to-the-extraordinary-general-meeting

    PHARMIWEB
    09 Feb 2026
    Share Share
    Immunotherapy Review Spotlights Clever-1 Inhibition
    Immunotherapy Review Spotlights Clever-1 Inhibition

    29 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-29/new-review-published-in-immunotherapy-highlights-the-potential-for-clever-1-inhibition-with-bexmaril

    PHARMIWEB
    29 Jan 2026
    Share Share
    Faron Expands Bexmarilimab Program With Phase I/II Trial
    Faron Expands Bexmarilimab Program With Phase I/II Trial

    27 Jan 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/faron-expands-bexmarilimab-program-in-solid-tumors-with-a-randomized-phase-i%2fii-bexar-1130903

    ACCESSWIRE
    27 Jan 2026
    Share Share
    Faron Collaborates With Institute For Cancer Research On BLAZE
    Faron Collaborates With Institute For Cancer Research On BLAZE

    22 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-22/faron-announces-strategic-collaboration-with-the-institute-for-cancer-research-to-launch-blaze-trial

    PHARMIWEB
    22 Dec 2025
    Share Share
    Faron Pharma Announces Nomination Board Composition
    Faron Pharma Announces Nomination Board Composition

    17 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-17/composition-of-faron-pharmaceuticals-shareholders-nomination-board

    PHARMIWEB
    17 Dec 2025
    Share Share
    Faron Issues Second €10M Tranche of Convertible Bonds
    Faron Issues Second €10M Tranche of Convertible Bonds

    11 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-11/faron-issues-second-tranche-of-bonds-with-an-aggregated-principal-amount-of-eur-10-million-under-its

    PHARMIWEB
    11 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search